Fda Regulatory Interpretation Cases

Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc.

Federal Circuit Upholds Merck's Januvia Patent Against Obviousness Challenge

Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc., decided by Federal Circuit on March 13, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck's patent for its b...